Zydus Lifesciences Limited Glibenclamide Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Glibenclamide Export Records India — #7 Exporter, 22 Shipments, $116.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Glibenclamide

India Pharmaceutical Trade Intelligence

$41.2M194 Suppliers100 CountriesHS 30049099

ExportsIndia → SRI LANKA89.8%India → TANZANIA1.6%

ImportsGERMANY → India$20.1K UNITED STATES → India$817

#1 Supplier: MEDOPHARM #1 Buyer: A,BAUR &

Zydus Lifesciences Limited — Glibenclamide Exporter #7 | $116.0K Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Glibenclamide Exporter Profile

Indian Pharmaceutical Exporter · #7 for Glibenclamide · $116.0K export value · DGFT Verified

Zydus Lifesciences Limited is the #7 Indian exporter of Glibenclamide with $116.0K in export value and 22 verified shipments. Zydus Lifesciences Limited holds a 0.3% market share in Glibenclamide exports across 5 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Glibenclamide Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Glibenclamide export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Lifesciences Limited Export Glibenclamide?

Country	Value	Shipments	Share
KENYA	$48.1K	11	41.5%
TANZANIA	$34.8K	4	30.0%
UGANDA	$20.8K	3	17.9%
YEMEN, DEMOCRATIC	$11.2K	3	9.7%
UNITED ARAB EMIRATES	$1.0K	1

Who Are the Top Buyers of Glibenclamide from Zydus Lifesciences Limited?

Buyer	Country	Value	Orders
ABACUS PHARMA (A) LTD	TANZANIA	$34.8K	4
ABACUS PHARMA (AFRICA) LTD	UGANDA	$34.5K	9
ABACUS PHARMA AFRICA LTD	UGANDA	$16.6K	2
ABACUS PHARMA (AFRICA) LIMITED	KENYA	$11.8K	2
AL-JABAL DRUGS AND MEDICAL APPLIANC	YEMEN, DEMOCRATIC	$11.2K	3
ABACUS PHARMA (AFRICA) LTD.,	UGANDA	$6.0K	1
WORLD HEALTH ORGANIZATION	UNITED ARAB EMIRATES	$1.0K	1

Zydus Lifesciences Limited supplies Glibenclamide to 7 buyers globally. The largest buyer is ABACUS PHARMA (A) LTD (TANZANIA), followed by ABACUS PHARMA (AFRICA) LTD (UGANDA) and ABACUS PHARMA AFRICA LTD (UGANDA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Glibenclamide Formulations Does Zydus Lifesciences Limited Export?

Product Description / Formulation	Value	Shipments
BETANASE 5MG TABLETS (GLIBENCLAMIDE) 5X3	$20.8K	4
BETANASE 5 MG TABS(GLIBENCLAMIDE)(5X3X10	$19.1K	2
BETANASE 5MG TABLETS (GLIBENCLAMIDE TABSBP) 5X3X10NOS	$11.8K	2
PHARMACEUTICALS MEDICINE FOR HUMAN USE-BETANASE 5 MG TABS (GLIBENCLAMIDE 5MG)5X3X10-QTY.12,450.000 PAC AS PER INVOICENOS	$11.2K	3
BETANASE 5MG TABLETS GLIBENCLAMIDE 5X3	$9.1K	1
BETANASE 5 MG TABS (GLIBENCLAMIDE) 5X3X10	$8.8K	1
BETANASE5 MG GLIBENCLAMIDE TABLET BP 5X3X10	$7.6K	1
BETANASE 5 MG TABS (GLIBENCLAMIDE) 5X3X1	$6.9K	1
BETANASE 5MG TABLETS(GLIBENCLAMIDE)(5X3X	$6.0K	1
BETANASE 5MG TABLETS (GLIBENCLAMIDE) 5X3X10	$5.3K	2

Zydus Lifesciences Limited exports 13 distinct Glibenclamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BETANASE 5MG TABLETS (GLIBENCLAMIDE) 5X3 with 4 shipments worth $20.8K.

How Does Zydus Lifesciences Limited Compare to Nearest Glibenclamide Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	CAPLIN POINT LABORATORIES LIMITED	$169.2K	17	5	$10.0K
6	LINCOLN PHARMACEUTICALS LTD	$124.9K	16	5	$7.8K
7	ZYDUS LIFESCIENCES LIMITED ★	$116.0K	22	5	$5.3K
8	MEDICAMEN BIOTECH LIMITED	$110.9K	11	8	$10.1K
9	RUSAN PHARMA LIMITED	$107.8K	3	1	$35.9K

Zydus Lifesciences Limited ranks #7 among 194 Indian Glibenclamide exporters. Average shipment value of $5.3K compared to the market average of $11.0K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and LINCOLN PHARMACEUTICALS LTD.

Which Indian Ports Ship Glibenclamide Exports?

Port	Shipments	% Share
SAHAR AIR	133	14.3%
NHAVA SHEVA SEA (INNSA1)	130	14.0%
SAHAR AIR CARGO ACC (INBOM4)	99	10.6%
JNPT/ NHAVA SHEVA SEA	61	6.6%
JNPT	45	4.8%
Bombay Air	33	3.5%
MUNDRA SEA	32	3.4%
AHEMDABAD ICD	27	2.9%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Glibenclamide Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Glibenclamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 22 individual customs records matching Zydus Lifesciences Limited exporting Glibenclamide, covering 13 formulations to 5 countries via 7 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 335+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Glibenclamide

Glibenclamide

Zydus Lifesciences Limited — Glibenclamide Exporter Profile

Zydus Lifesciences Limited — Glibenclamide Export Profile: Buyers & Destinations

Where Does Zydus Lifesciences Limited Export Glibenclamide?

Who Are the Top Buyers of Glibenclamide from Zydus Lifesciences Limited?

What Is India's Total Glibenclamide Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Glibenclamide Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Glibenclamide Exporters?

What Glibenclamide Formulations Does Zydus Lifesciences Limited Export?

How Does Zydus Lifesciences Limited Compare to Nearest Glibenclamide Exporters?

Which Indian Ports Ship Glibenclamide Exports?

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Glibenclamide Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Glibenclamide Export Data from Zydus Lifesciences Limited

Glibenclamide Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source